Also known as Geodon
Ziprasidone (marketed as Geodon, Zeldox by Pfizer) was the fifth atypical antipsychotic to gain approval (February 2001) in the United States. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia, and acute mania and mixed states associated with bipolar disorder. Its intramuscular injection form is approved for acute agitation in schizophrenic patients for whom treatment with just ziprasidone is appropriate.Source: Wikipedia
Estimated Total Cost: $410.62 for an average of 28 days supply
Patients are most commonly prescribed ziprasidone to treat bipolar disorder, schizophrenia, depressive or psychotic symptoms, and psychotic disorder.
Patients taking ziprasidone most commonly experience side effects like schizophrenia, headache, and nausea.
|High blood pressure|
|Decreased heart rate|
|Difficulty in swallowing|
|Shortness of breath|
|Increased heart rate|
|Fungal infection of the skin|
|Tooth disorder (Tooth Disease)|